Apollo Endosurgery's net tangible assets is $33M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Apollo Endosurgery's net tangible assets stands at $33M as of December 2022. That compares with $61M in the prior-year period — down 46.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Apollo Endosurgery reported $33M in net tangible assets versus $61M a year earlier — a 46.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $61M in the prior-year period — down 46.8% year over year. Sustained growth in net tangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Apollo Endosurgery's net tangible assets evolved across reporting periods, while the comparison chart places APEN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, net tangible assets is commonly used to spot outliers. Apollo Endosurgery's reading of $33M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.